Displaying 51 - 100 of 179 results
Released Company Title Industry Topic
06 Nov 2023
12:00 CET
BERGENBIO BerGenBio ASA: Invitation to third quarter 2023 results webcast 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
06 Nov 2023
07:00 CET
BERGENBIO BerGenBio Announces Data from Biomarker Analyses in 2L NSCLC 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
02 Nov 2023
14:00 CET
BERGENBIO BerGenBio Announces Poster Presentation at Upcoming ASH Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
31 Oct 2023
14:00 CET
BERGENBIO BerGenBio Announces Poster Presentation at Upcoming SITC Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
23 Oct 2023
07:30 CEST
BERGENBIO New Data on BerGenBio's Selective AXL Inhibitor Bemcentinib Released Today at 2023 ESMO Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Oct 2023
07:00 CEST
BERGENBIO Additional data on BerGenBio's selective AXL inhibitor bemcentinib to be presented at the 2023 ESMO meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
11 Sep 2023
07:00 CEST
BERGENBIO BerGenBio to Present Company Update at H.C. Wainright Annual Global Investment Conference 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
27 Aug 2023
20:35 CEST
BERGENBIO Correction: BerGenBio ASA Seccond Quarter and half year 2023 Financial Report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
23 Aug 2023
07:00 CEST
BERGENBIO BerGenBio Reports Second Quarter 2023 Financial Results 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
22 Aug 2023
10:30 CEST
BERGENBIO BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Aug 2023
07:00 CEST
BERGENBIO BerGenBio ASA: Invitation to second quarter and half year 2023 results webcast 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
29 Jun 2023
14:39 CEST
BERGENBIO BerGenBio ASA: Share capital increase registered 20103010 Biotechnology Total number of voting rights and capital
27 Jun 2023
13:10 CEST
BERGENBIO BerGenBio ASA: Resolution to increase the share capital for settlement of underwriting commission 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
23 Jun 2023
07:00 CEST
BERGENBIO BerGenBio ASA - Information about the Warrants issued in connection with the Rights Issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
22 Jun 2023
12:36 CEST
BERGENBIO BerGenBio ASA - Correction, new share capital and warrants registered 20103010 Biotechnology Total number of voting rights and capital
22 Jun 2023
11:36 CEST
BERGENBIO BerGenBio ASA - New share capital and warrants registered 20103010 Biotechnology Total number of voting rights and capital
22 Jun 2023
07:00 CEST
BERGENBIO BerGenBio Reports First Quarter 2023 Financial Results and Provides Business Update 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
19 Jun 2023
16:40 CEST
BERGENBIO BerGenBio ASA - Updated timeline for delivery of Offer Shares and Warrants in connection with the Rights Issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
15 Jun 2023
08:10 CEST
BERGENBIO BerGenBio ASA - Mandatory notification of trade, allocations to primary insiders and close associates in the Rights Issue 20103010 Biotechnology Mandatory notification of trade primary insiders
14 Jun 2023
17:21 CEST
BERGENBIO BergenBio ASA - Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
14 Jun 2023
16:48 CEST
BERGENBIO BerGenBio - Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
14 Jun 2023
15:20 CEST
BERGENBIO BerGenBio ASA - Correction of final results of the Rights Issue 20103010 Biotechnology Inside information
14 Jun 2023
13:30 CEST
BERGENBIO BerGenBio ASA - Final results of the Rights Issue 20103010 Biotechnology Inside information
13 Jun 2023
20:30 CEST
BERGENBIO BerGenBio ASA - Preliminary results indicates an oversubscribed Rights Issue of gross NOK 250 million 20103010 Biotechnology Inside information
13 Jun 2023
09:49 CEST
BERGENBIO Mandatory notification of trade by Primary Insiders and close associates 20103010 Biotechnology Mandatory notification of trade primary insiders
13 Jun 2023
07:00 CEST
BERGENBIO BerGenBio ASA - Last day of the Subscription Period in the Rights Issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
08 Jun 2023
22:01 CEST
BERGENBIO Mandatory notification of trade by Primary Insiders and close associates 20103010 Biotechnology Mandatory notification of trade primary insiders
07 Jun 2023
17:20 CEST
BERGENBIO Mandatory notification of trade by Primary Insiders and close associates 20103010 Biotechnology Mandatory notification of trade primary insiders
07 Jun 2023
07:00 CEST
BERGENBIO BerGenBio ASA - Last day of trading in Subscription Rights 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
06 Jun 2023
16:47 CEST
BERGENBIO BerGenBio - Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
05 Jun 2023
22:11 CEST
BERGENBIO BerGenBio Announces Data from Bemcentinib Trial in Mesothelioma Presented at ASCO 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
30 May 2023
18:19 CEST
BERGENBIO BerGenBio to Participate in Investor Webcast and Q&A 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
30 May 2023
13:28 CEST
BERGENBIO BerGenBio ASA: Receipt of subscription rights in the rights issue by primary insiders and their close associates 20103010 Biotechnology Mandatory notification of trade primary insiders
30 May 2023
07:00 CEST
BERGENBIO BerGenBio ASA - Commencement of the subscription period for the rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
26 May 2023
14:41 CEST
BERGENBIO BerGenBio ASA: Approval and publication of prospectus for the preferential Rights Issue 20103010 Biotechnology Prospectus / admission document
25 May 2023
08:04 CEST
BERGENBIO Shareholder disclosure 20103010 Biotechnology Major shareholding notifications
25 May 2023
07:00 CEST
BERGENBIO BerGenBio Announces Abstracts Accepted for Presentation at 2023 ASCO 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
24 May 2023
20:12 CEST
BERGENBIO Mandatory notification of trade by related party to Primary Insiders 20103010 Biotechnology Mandatory notification of trade primary insiders
23 May 2023
07:00 CEST
BERGENBIO BGBIO - Ex. subscription rights today 20103010 Biotechnology Ex Date
22 May 2023
18:01 CEST
BERGENBIO BerGenBio ASA: Annual general meeting held 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
20 May 2023
12:05 CEST
BERGENBIO BerGenBio ASA - Updated key information relating to the preferential rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
20 May 2023
12:00 CEST
BERGENBIO BERGENBIO ASA - Terms of the partially underwritten rights issue 20103010 Biotechnology Inside information
09 May 2023
18:14 CEST
BERGENBIO Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
09 May 2023
18:14 CEST
BERGENBIO BerGenBio to hold business update conference call 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 Apr 2023
15:00 CEST
BERGENBIO BERGENBIO ASA: Notice of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 Apr 2023
13:01 CEST
BERGENBIO BERGENBIO ASA: Board approval of 2022 Annual Financial Statement and Annual Report 2022 20103010 Biotechnology Annual financial and audit Reports
25 Apr 2023
17:56 CEST
BERGENBIO BerGenBio ASA - Key information relating to the preferential rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
25 Apr 2023
17:49 CEST
BERGENBIO Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
25 Apr 2023
17:48 CEST
BERGENBIO BerGenBio ASA: Foreslår delvis garantert fortrinnsrettsemisjon 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
25 Apr 2023
17:48 CEST
BERGENBIO BerGenBio ASA: Proposed partially underwritten rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State